Select one country
| Western Europe | Northern Europe | Southern Europe | Eastern Europe | Northern America | Latin America | Asia | Oceania | Africa | ||
| PE Guidelines | Belgium France Germany Switzerland The Netherlands | Baltic (Latvia, Lithuania, Estonia) Ireland Norway Sweden | Portugal | Slovak Republic Slovenia | Canada | Brazil Colombia Cuba MERCOSUR (Argentina, Brazil, Paraguay, Uruguay) México | Japan Malaysia South Korea Taiwan | New Zealand | Egypt | |
| Submission Guidelines | England & Wales Finland Scotland | Spain - Regions | Czech Republic Poland | United States of America | Iran Israel Thailand | Australia | ||||
| Published PE Recommendations | Austria | Denmark | Croatia Italy Spain | Hungary Russian Federation | United States of America | China Mainland | South Africa |
If you would like your country's pharmacoeconomics guidelines at the ISPOR website or have comments concerning this section of the ISPOR website, email your request to mailto:PEguidelines@ispor.org